TrialBlood cancer journal2019

Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10).

F Hitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.